Views & Analysis

Debates & Insight
Doctor networks: The rules of engagement for pharma
Sponsored

Doctor networks: The rules of engagement for pharma

As online doctor networks have grown they have also developed their own rules around how members interact, what sort of information they are looking for and how they like to engage, meaning pha

Debates & Insight
The Healthcare Meetings Forum 2013
Sponsored

The Healthcare Meetings Forum 2013

Healthcare meetings are experiencing a time of change, as new compliance regulations, the rise of digital and the flexing needs of healthcare providers force adaptation.

Debates & Insight
How to effectively engage in the rare disease space
Sponsored

How to effectively engage in the rare disease space

Engaging with the relevant healthcare stakeholders for pharma company sales forces increasingly requires on-going adapatation and new skills, but engaging in the rare disease space is even hard

Debates & Insight
Outcomes shape the new payer networks for pharma
Sponsored

Outcomes shape the new payer networks for pharma

The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which the pharma i